| Literature DB >> 28489273 |
Samia M Esmat1, Rehab A Hegazy1, Heba I Gawdat1, Rania M Abdel Hay1, Riham S Allam2, Rofaida El Naggar1, Hoda Moneib3.
Abstract
BACKGROUND: Female pattern hair loss (FPHL) is the most common form of hair loss in women. Nevertheless, its management represents a real challenge. Among the FDA approved therapeutic modalities for FPHL are topical minoxidil and more recently low-level light therapy (LLLT). AIM OF WORK: Assess the efficacy and safety of LLLT in comparison to topical minoxidil 5% and to a combination of both therapies in the treatment of FPHL. PATIENTS AND METHODS: This study included 45 female patients with proven FPHL. They were randomly divided into three equal groups, where group (i) patients were instructed to apply topical minoxidil 5% twice daily, group (ii) patients received LLLT using the helmet iGrow® device for 25 minutes 3 days weekly, and group (iii) patients received a combination of both topical minoxidil 5% twice daily and LLLT for 25 minutes 3 days weekly for 4 months (study duration). Evaluation was done according to clinical, dermoscopic (folliscopic), and ultrasound bio-microscopic (UBM) parameters. Patient satisfaction and side effects were reported.Entities:
Keywords: UBM; dermoscope; female pattern hair loss; low light laser therapy; minoxidil
Mesh:
Substances:
Year: 2017 PMID: 28489273 DOI: 10.1002/lsm.22684
Source DB: PubMed Journal: Lasers Surg Med ISSN: 0196-8092 Impact factor: 4.025